FIGURE 2.
Analysis of CSDE1 transcript expression in melanoma patient samples. (A) Total CSDE1 mRNA levels in melanocytes, nevi, and melanoma samples. Transcript abundance is expressed in TPM (transcripts per million). Significance was assessed by t-test with Bonferroni correction (ns, not significant, ***P ≤ 0.001). (B) CSDE1 isoform expression stratifying samples according to two transcriptomic signatures (see main text for details). MAPKi, samples from patients treated with MAPK inhibitors. Transcript identities are indicated on the right. Significance was assessed with ANOVA (***P ≤ 0.001).
